Search

Search results

Genetic testing: an essential topic for discussion with the IRD community

As Luxturna reaches the clinic and other gene-specific therapies for inherited retinal disease get closer to the end of the development pipeline, it is becoming ever more important that affected families can access a genetic diagnosis, potentially opening up choices around treatment and clinical trial participation.

Virtual delegate bag

A virtual delegate bag for our online attendees - Professionals' Conference 2024

Our affiliations

We are proud to work with a number of organisations that share our aims and values.